Zeliha Emrence

1.5k total citations
19 papers, 177 citations indexed

About

Zeliha Emrence is a scholar working on Molecular Biology, Hematology and Rheumatology. According to data from OpenAlex, Zeliha Emrence has authored 19 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Rheumatology. Recurrent topics in Zeliha Emrence's work include Acute Myeloid Leukemia Research (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Zeliha Emrence is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Zeliha Emrence collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. Zeliha Emrence's co-authors include Duran Üstek, Ebru Toksoy Öner, Neslihan Abacı, Kazım Yalçın Arğa, Fulya Coşan, Ayşe Çefle, Muzaffer Arıkan, Günnur Deniz, Tuğba Özer and Esin Aktaş Çetin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Bacteriology.

In The Last Decade

Zeliha Emrence

16 papers receiving 175 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeliha Emrence Türkiye 10 88 33 30 29 26 19 177
Marianne Kieffer Denmark 9 29 0.3× 26 0.8× 11 0.4× 25 0.9× 28 1.1× 10 381
Sara Zuber Italy 9 32 0.4× 80 2.4× 20 0.7× 22 0.8× 3 0.1× 16 299
Rowan Callahan United States 7 170 1.9× 13 0.4× 15 0.5× 53 1.8× 10 293
Т. А. Демура Russia 9 121 1.4× 54 1.6× 5 0.2× 26 0.9× 5 0.2× 76 363
Zoë C. Wong United States 7 48 0.5× 29 0.9× 75 2.5× 32 1.1× 13 207
Jiro Kera Japan 5 35 0.4× 123 3.7× 38 1.3× 6 0.2× 84 3.2× 8 236
Amanda Sankar United States 4 122 1.4× 10 0.3× 116 3.9× 14 0.5× 2 0.1× 11 270
Artem Rubinstein Russia 11 32 0.4× 45 1.4× 8 0.3× 19 0.7× 3 0.1× 36 212
Geneviève Fortin Canada 6 51 0.6× 262 7.9× 9 0.3× 26 0.9× 6 0.2× 7 333
Eunhye Choi South Korea 7 52 0.6× 41 1.2× 6 0.2× 40 1.4× 1 0.0× 10 203

Countries citing papers authored by Zeliha Emrence

Since Specialization
Citations

This map shows the geographic impact of Zeliha Emrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeliha Emrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeliha Emrence more than expected).

Fields of papers citing papers by Zeliha Emrence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeliha Emrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeliha Emrence. The network helps show where Zeliha Emrence may publish in the future.

Co-authorship network of co-authors of Zeliha Emrence

This figure shows the co-authorship network connecting the top 25 collaborators of Zeliha Emrence. A scholar is included among the top collaborators of Zeliha Emrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeliha Emrence. Zeliha Emrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Emrence, Zeliha, Özlem Akgün, Ayşe Tanatar, et al.. (2025). NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis. Lara D. Veeken. 64(10). 5509–5517. 1 indexed citations
2.
Emrence, Zeliha, Kazım Yalçın Arğa, Fatma Alıbaz-Öner, et al.. (2024). Cytokine Signature Differences in Major Phenotypic Groups of Behçet Disease. JCR Journal of Clinical Rheumatology. 30(8). e178–e184. 1 indexed citations
3.
Emrence, Zeliha, Tuğrul Elverdi, Muhlis Cem Ar, et al.. (2023). Upregulation of SPINK2 in acute myeloid leukemia. SHILAP Revista de lepidopterología. 4(1). 92–97.
4.
Emrence, Zeliha, et al.. (2022). Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Behçet disease. Lara D. Veeken. 62(5). 1903–1909. 9 indexed citations
5.
Emrence, Zeliha, et al.. (2020). LEF1 Induces DHRS2 Gene Expression in Human Acute Leukemia Jurkat T-Cells. Turkish Journal of Hematology. 37(4). 226–233. 4 indexed citations
6.
Taşkın, Eylem, et al.. (2020). Silencing HMGB1 expression inhibits adriamycin's heart toxicity via TLR4 dependent manner through MAPK signal transduction.. PubMed. 25(1). 554–565. 13 indexed citations
7.
Coşan, Fulya, Esin Aktaş Çetin, Nilgün Akdeniz, et al.. (2017). Natural Killer Cell Subsets and Their Functional Activity in Behçet’s Disease. Immunological Investigations. 46(4). 419–432. 28 indexed citations
8.
Örmeci, Aslı, Zeliha Emrence, Bülent Baran, et al.. (2016). Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole.. PubMed. 20(5). 879–85. 10 indexed citations
9.
Örmeci, Aslı, Zeliha Emrence, Bülent Baran, et al.. (2016). Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?. PubMed. 20(9). 1795–7. 12 indexed citations
10.
Özer, Tuğba, Muzaffer Arıkan, Zeliha Emrence, et al.. (2015). Genomic analysis reveals the biotechnological and industrial potential of levan producing halophilic extremophile, Halomonas smyrnensis AAD6T. SpringerPlus. 4(1). 393–393. 36 indexed citations
11.
Gül, Ahmet, Huri Özdoğan, Serdal Uğurlu, et al.. (2015). Pathological and immunological features of autoinflammatory syndrome associated with lymphedema (AISLE). Pediatric Rheumatology. 13(S1).
12.
Demır, Kadir, Aslı Örmeci, Zeliha Emrence, et al.. (2013). Sa1915 Effect of Genotypic Differences in CYP2C19 and on Cure Rates for Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors. Gastroenterology. 144(5). S–333. 1 indexed citations
13.
Özbek, Emin, Emre Can Polat, Levent Özcan, et al.. (2012). TT polymorphism in rs2165241 and rs1048661 region in lysyl oxidase like‐1 gene may have a role in stress urinary incontinence physiopathology. Journal of obstetrics and gynaecology research. 39(1). 237–242. 8 indexed citations
14.
Üstek, Duran, Muzaffer Arıkan, Aris Çakiris, et al.. (2012). A genome-wide analysis of lentivector integration sites using targeted sequence capture and next generation sequencing technology. Infection Genetics and Evolution. 12(7). 1349–1354. 12 indexed citations
15.
Coşan, Fulya, Zeliha Emrence, Hülya Azaklı, et al.. (2012). The association of TNFRSF1A gene and MEFV gene mutations with adult onset Still’s disease. Rheumatology International. 33(7). 1675–1680. 10 indexed citations
16.
Ekmekçi, Cumhur Gökhan, Ayten Kandilci, Zeliha Emrence, et al.. (2012). SET oncogene is upregulated in pediatric acute lymphoblastic leukemia.. PubMed. 98(2). 252–6. 9 indexed citations
17.
Emrence, Zeliha, Aris Çakiris, Neslihan Abacı, et al.. (2012). Draft Genome Sequence of Halomonas smyrnensis AAD6 T. Journal of Bacteriology. 194(20). 5690–5691. 14 indexed citations
18.
Ekmekçi, Cumhur Gökhan, Ayten Kandilci, Zeliha Emrence, et al.. (2012). SET Oncogene is Upregulated in Pediatric Acute Lymphoblastic Leukemia. Tumori Journal. 98(2). 252–256. 9 indexed citations
19.
Abacı, Neslihan, Fulya Coşan, Hülya Azaklı, et al.. (2012). AB0003 XBP1 splicing and reduced XBP1 expression in behçet's disease. Annals of the Rheumatic Diseases. 71. 637–637.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianne Kieffer Breakdown of academic impact, for papers by Sara Zuber Breakdown of academic impact, for papers by Rowan Callahan Breakdown of academic impact, for papers by Т. А. Демура Breakdown of academic impact, for papers by Zoë C. Wong Breakdown of academic impact, for papers by Jiro Kera Breakdown of academic impact, for papers by Amanda Sankar Breakdown of academic impact, for papers by Artem Rubinstein Breakdown of academic impact, for papers by Geneviève Fortin Breakdown of academic impact, for papers by Eunhye Choi
Rankless by CCL
2026